280 MITOCHONDRIAL ELECTRON TRANSFER
the protein complex in a lipid bilayer. Again and again, such preparations
contained cardiolipin (e.g., 405 – 408 ). Cardiolipin has become the “ signature
lipid of mitochondria ” (see Section 6.6 ), and it became “ conventional wisdom ”
to postulate that cardiolipin may be essential for either the assembly of these
complexes in the membrane or their maintenance in their functional confor-
mation (e.g., 409, 410 ).
An experimental test for this idea became possible when genetic approaches
were used to eliminate cardiolipin by mutating the specifi c enzymes required
for its biosynthesis (see Section 6.6). In mammalian cells in tissue culture, this
has been achieved by Ohtsuka et al. (411, 412) , who isolated Chinese hamster
mutants with a defect in phosphotidylglycerophosphate synthase. Such cells had
depleted cardiolipin levels and exhibited mitochondrial dysfunction. Complex
I appeared to be the most seriously affected. In contrast, the initial studies with
a yeast mutant containing a defective cardiolipin synthase gene, cls1 , gave the
surprising result that such mutants were viable and capable of respiration;
that is, they grew in the presence of either nonfermentable or fermentable
carbon sources. These molecular – genetic studies in yeast have now been greatly
expanded. The relevant enzymes and genes required for the biosynthesis have
been identifi ed to be used for genetic manipulations (413) . It emerges that the
biosynthesis of cardiolipin is highly regulated by several mechanisms. Some of
these could be expected to be linked to mitochondrial biogenesis in general, but
there are also specifi c controls mediated by inositol and by the mitochondrial
pH (414, 415) . Thus, mutant mitochondria with a defective assembly of the elec-
tron transport chain exhibit decreased cardiolipin synthesis. While cardiolipin
may not be absolutely essential for the assembly and activity of the electron
transport chain, experiments suggest that it plays a role in stabilizing respiratory
chain supercomplexes (36, 416) . Needless to say, its implication in the process of
apoptosis has also been investigated (417 – 419) . One hypothesis is that the oxi-
dation of cardiolipin by ROS reduces cytochrome c binding to the inner mem-
brane and thus enhances cytochrome c release.
A combination of HPLC, mass spectroscopy, and selective enzymatic cleav-
age has shown that cardiolipin from different organisms and different tissues
contains only one or two types of fatty acids (out of four per molecule of CL),
suggesting a “ high degree of structural uniformity and molecular symmetry ”
(420) . Is this critical? One affi rmative answer comes from the elucidation of
the defect in the Barth syndrome in humans, an X - linked cardio - and skeletal
myopathy (415, 416, 421 – 423) . Progress in our understanding of the molecular
basis for this syndrome came from the identifi cation/cloning of the human
gene (TAZ, encoding tafazzin), followed by the fi nding, characterization, and
manipulation of homologous genes in yeast and Drosophila . As discussed
further in Section 6.6, cardiolipin is synthesized de novo , but is then “ remod-
eled ” to contain an increased proportion of unsaturated fatty acids (e.g.,
linoleic acid). Tafazzin is required for this remodeling of cardiolipin. It has
been characterized as a 1 - palmitoyl - 2 - [14C]linoleoyl - phosphatidylcholine:
monolysocardiolipin linoleoyltransferase (424) . Drosophila melanogaster